Technology-enhanced Transitional Palliative Care for Family Caregivers

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the effect and cost of technology-enhanced transitional palliative care on family caregivers who provide care to a loved one after a hospitalization.

Clinical Trial Description

There will be two groups in this randomized control study: technology-enhanced group and usual care group. The total amount of subjects includes both the palliative care recipients and the family caregivers (both the patients and their family caregiver will sign informed consent.) A family caregiver is broadly defined as the person self-identified as the family member or unpaid friend who is the primary informal caregiver for a patient with a terminal illness. The family caregiver may or may not be a member of the patient's nuclear family. For the technology-enhanced group, the study nurse experienced in palliative care will have a visit with the caregiver within the first 24 hours after consent, and have daily visits with the caregiver as long as the patient is still in the hospital. During these visits, the nurse will talk to the caregiver about their own self-care needs, begin transitional care planning, and develop Readiness Plans to anticipate care giving needs the caregiver may have when they discharge from the hospital. For the technology-enhanced group, the caregiver will take an iPad home so that the study team nurse can video chat with them. The iPad will need to be returned upon completion of the study. The study nurse will have a video chat with the caregiver at home within 24-48 hours of discharge from the hospital, and at least weekly for 8 weeks after that. The caregiver and the study nurse may also decide to have other calls on the phone during this time. For the usual care group, doctors and nurses along with input from the Palliative Care service will help the caregiver make a plan for discharge from the hospital and for taking care of the patient upon discharge. Someone from the study team will call the caregiver once a month to check in for the 6 months after the patient discharges from the hospital. Both groups will be asked to complete questionnaires before starting the study, and then up to seven more times over the course of 6 months. ;

Study Design

Related Conditions & MeSH terms

Palliative Care

Clinical Trial Details

NCT number	NCT03339271
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	March 20, 2018
Completion date	July 5, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04673760` - The PROAKTIV Study	N/A
Completed	`NCT03520023` - Critical Care and Palliative Care Medicine Together in the ICU	N/A
Completed	`NCT01990742` - Improving Palliative Care Through Teamwork	N/A
Not yet recruiting	`NCT05434208` - Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)	N/A
Not yet recruiting	`NCT03267706` - Introducing the Palliative Care Comprehensive Tool in Family Medicine	N/A
Completed	`NCT02845817` - Requests for Euthanasia and Assisted Suicide	N/A
Recruiting	`NCT02778347` - Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Completed	`NCT01934413` - Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study	N/A
Recruiting	`NCT01170000` - Timely End-of-Life Communication to Parents of Children With Brain Tumors	N/A
Recruiting	`NCT04052074` - Complementary Therapy in Home Palliative Care Patients and Their Caregivers	N/A
Recruiting	`NCT05935540` - ACP-Family Programme for Palliative Care Patients and Their Family Member	N/A
Active, not recruiting	`NCT02689375` - A Prospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin	N/A
Recruiting	`NCT05520281` - Short-term Psychodynamic Psychotherapy in Serious Physical Illness	N/A
Completed	`NCT06140004` - Home-Based Palliative Care Impact on Providers
Completed	`NCT04333719` - Prevalence of Deep Sedation in Terminal Palliative Phase
Recruiting	`NCT03286127` - Palliative Outcome Evaluation Muenster I
Completed	`NCT06211816` - Efficacy of End-of-life Communication Strategies on Nurses in the Intensive Care Unit	N/A
Completed	`NCT04857060` - Palliative Care Educator	N/A
Completed	`NCT04491110` - Intervention to Improve Quality of Sleep of Palliative Patient Carers in the Community: Clinical Trial	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.